Thu, March 3, 2011
Wed, March 2, 2011
Tue, March 1, 2011
Mon, February 28, 2011
Sun, February 27, 2011
Fri, February 25, 2011
Thu, February 24, 2011
Wed, February 23, 2011
Tue, February 22, 2011
[ Tue, Feb 22nd 2011 ]: Market Wire
PROTOX APPOINTS NEW DIRECTORS
Mon, February 21, 2011
Sun, February 20, 2011
Fri, February 18, 2011
Thu, February 17, 2011
Wed, February 16, 2011
Tue, February 15, 2011

Inspire Announces Webcast of Presentation at Citi Global Healthcare Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2011/ .. tation-at-citi-global-healthcare-conference.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

RALEIGH, N.C.--([ BUSINESS WIRE ])--Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Adrian Adams, President and CEO, will present at the Citi Global Healthcare Conference on Wednesday, March 2, 2011 at 10:30 am ET in New York City.

The webcast of the presentation will be available on Inspire's website at [ www.inspirepharm.com ]. An archived version of the webcast presentation will also be available through this link for a limited time following the conference.

About Inspire

Inspire is a specialty pharmaceutical company focused on developing and commercializing ophthalmic products. Inspirea™s strategy is to create a sustainable portfolio of products by leveraging its commercial capabilities and pipeline assets and pursuing corporate development and licensing opportunities. Inspirea™s specialty eye care sales force generates revenue from the promotion of AZASITE® (azithromycin ophthalmic solution) 1% for bacterial conjunctivitis and the co-promotion of ELESTAT® (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis. Inspire receives royalties based on net sales of RESTASIS® (cyclosporine ophthalmic emulsion) 0.05% for dry eye and expects to begin receiving royalties in 2011 based on net sales of DIQUASa" Ophthalmic Solution 3% (diquafosol tetrasodium) for dry eye. For more information, visit [ www.inspirepharm.com ].


Publication Contributing Sources